Evidence map›Paper›PMID 42788337›Full record

ArticleAnimal models and experimental medicine2026

Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis.

Céline-Hivda Yegen, Zakaria Maakoul, Dominique Marchant, Patrice Callard, Julia Bourse, Jean-François Bernaudin, Hilario Nunes, Carole Planès, Emilie Boncoeur, Nicolas Voituron

Abstract read
In one paragraph

Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Céline-Hivda YegenLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Zakaria MaakoulLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Dominique MarchantLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Patrice CallardFaculté de Médecine, Sorbonne Université, Paris, France.
Julia BourseLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Jean-François BernaudinLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Hilario NunesLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Carole PlanèsLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Emilie BoncoeurLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.
Nicolas VoituronLaboratoire Hypoxie & Poumon, INSERM, U1272, Université Sorbonne Paris-Nord, Bobigny, France.ORCID https://orcid.org/0000-0002-2092-4900

Funding

Chancellerie des Universités de Paris Legs Poix 2018"Institut Fédératif de Recherche Biomédicale" programs of the Université Sorbonne Paris Nord NV-2020
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is the archetypal form of progressive pulmonary fibrosis (PPF), as well as being the most common and severe type of interstitial lung disease. IPF is characterized by progressive, diffuse interstitial remodeling, stiffening of the lung parenchyma and is also most often associated with pulmonary hypertension (PH), which significantly impacts the clinical course and outcome of the disease. To improve targeted therapeutic options and survival predictions, as well as offering an overall better understanding of the disease, researchers need models that best reflect the characteristics observed in patients and allow the study of comorbidities associated with pulmonary fibrosis. Chronic pulmonary fibrosis was induced in male C57BL/6 mice through intratracheal instillation (ITI) of 3 low-doses of bleomycin (BLM) every 2 weeks. Mice were sacrificed 15 or 90 days after the last ITI. Clinical follow-up and histological analysis were performed to study lung and perivascular remodeling. Our results suggest that fractionated bleomycin instillation generates a persistent and progressive pulmonary fibrosis in mice. This is associated with collagen remodeling in the perivascular space outside fibrotic areas. We hypothesize that this remodeling, accompanied by a mild but significant increase in pulmonary artery media thickness, could be a precursor to pulmonary fibrosis-associated hypertension. These results suggest that this model could improve our understanding of pulmonary remodeling and vascular lesions in the early stages of pulmonary fibrosis.

Indexed as

bleomycinmouse modelperivascular remodelingprogressive pulmonary fibrosispulmonary hypertension

Identifiers

PMID42788337
PMCPMC13613283

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.